קלוקסצילין-מדו 1 גר'  إسرائيل - العبرية - Ministry of Health

קלוקסצילין-מדו 1 גר'

a.l. medi-market ltd. - cloxacillin as sodium - אבקה להמסה להזרקה\אינפוזיה - cloxacillin as sodium 1000 mg/vial - cloxacillin

דולוקסטין- מדו 30 מג إسرائيل - العبرية - Ministry of Health

דולוקסטין- מדו 30 מג

a.l. medi-market ltd. - duloxetine as hydrochloride - duloxetine as hydrochloride 30 mg - duloxetine

דולוקסטין- מדו 60 מג إسرائيل - العبرية - Ministry of Health

דולוקסטין- מדו 60 מג

a.l. medi-market ltd. - duloxetine as hydrochloride - duloxetine as hydrochloride 60 mg - duloxetine

אמוקסיצילין מדו 500 מג כמוסות إسرائيل - العبرية - Ministry of Health

אמוקסיצילין מדו 500 מג כמוסות

a.l. medi-market ltd. - amoxicillin as trihydrate - קפסולות - amoxicillin as trihydrate 500 mg - amoxicillin

אמיודקור זריקות إسرائيل - العبرية - Ministry of Health

אמיודקור זריקות

sanofi israel ltd - amiodarone hydrochloride - תמיסה להזרקה - amiodarone hydrochloride 50 mg / 1 ml - amiodarone - amiodarone - corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.

אגרסטט إسرائيل - العبرية - Ministry of Health

אגרסטט

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate - תמיסה לאינפוזיה - tirofiban as hydrochloride monohydrate 0.05 mg/ml - tirofiban - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

אגרסטט إسرائيل - العبرية - Ministry of Health

אגרסטט

tzamal bio-pharma ltd - tirofiban as hydrochloride monohydrate 0.25 mg/ml - solution for infusion - tirofiban - aggrastat in combination with heparin, is indicated for patients with unstable angina or non-q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for the treatment of acute coronary syndrome, including patients who are to be managed medically and those undergoing ptca or atherectomy. in this setting, aggrastat has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction or refractory ischemia/repeat cardiac procedure.

טסטומקס 25 מג إسرائيل - العبرية - Ministry of Health

טסטומקס 25 מג

padagis israel pharmaceuticals ltd, israel - testosterone - ג'ל - testosterone 25 mg/dose - testosterone - testosterone - testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

אנדרוג'ל 50 מג إسرائيل - العبرية - Ministry of Health

אנדרוג'ל 50 מג

cts ltd - testosterone - ג'ל - testosterone 0.05 mg/sachet - testosterone - testosterone - testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

טסטומקס 50 מג إسرائيل - العبرية - Ministry of Health

טסטומקס 50 מג

padagis israel pharmaceuticals ltd, israel - testosterone - ג'ל - testosterone 50 mg/dose - testosterone and estrogen - testosterone and estrogen - testosterone replacement therapy for males hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.